#PureScience #Covid19
The AstraZeneca-Oxford vaccine has now had two participants report rare neurological reactions in a span of two months. ThePrint’s Sandhya Ramesh takes a look at these concerning findings and the implications for the viability fo the vaccine.
———————————————————————————————
AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints
———————————————————————————————
Participant information sheet:
———————————————————————————————
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
——————————————————————————————————————————————————————
Connect with ThePrint
» Subscribe to ThePrint :
» Like us on Facebook:
» Tweet us on Twitter:
» Follow us on Instagram:
» Find us on LinkedIn :
» Subscribe to ThePrint on Telegram:
